ArticleFrontiers in oncology2022

Chidamide Maintenance Therapy Following Induction Therapy in Patients With Peripheral T-Cell Lymphoma Who Are Ineligible for Autologous Stem Cell Transplantation: Case Series From China.

Wei Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.